Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 28, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▲ |
|---|---|---|---|
| 7DXA | P12238 | PSII intermediate Psb28-RC47 | |
| 7DXA | P12239 | PSII intermediate Psb28-RC47 | |
| 7DXA | P19052 | PSII intermediate Psb28-RC47 | |
| 7DXA | P12240 | PSII intermediate Psb28-RC47 | |
| 7DXA | P12241 | PSII intermediate Psb28-RC47 | |
| 7DXA | P12312 | PSII intermediate Psb28-RC47 | |
| 7DXA | P12313 | PSII intermediate Psb28-RC47 | |
| 7DXA | D0VWR4 | PSII intermediate Psb28-RC47 | |
| 7E6Q | A1ILL9 | Crystal structure of influenza A virus neuraminidase N5 complexed with 4'-phenyl-1,2,3-triazolylated oseltamivir carboxylate | |
| 7E6X | Q8RUT8 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 4 ms structure | |
| 7E6X | Q93WP2 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 4 ms structure | |
| 7E6Y | Q8RUT8 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 1 microsecond structure | |
| 7E6Y | Q93WP2 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 1 microsecond structure | |
| 7E6Z | Q8RUT8 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 50 microsecond structure | |
| 7E6Z | Q93WP2 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 50 microsecond structure | |
| 7EB5 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2 | |
| 7EFN | A0A5G2QYH2 | Crystal structure of the gastric proton pump K791S/E820D/Y340N/E936V in (BYK)E2BeF state | |
| 7EFN | P18434 | Crystal structure of the gastric proton pump K791S/E820D/Y340N/E936V in (BYK)E2BeF state | |
| 7EYA | 7EYA | Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-804 Fab | |
| 7EYA | P0DTC2 | Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-804 Fab | |
| 7FD9 | P41594 | Thermostabilised full length human mGluR5-5M with orthosteric antagonist, LY341495 | |
| 7JHM | Q9NY97 | Structure of human beta 1,3-N-acetylglucosaminyltransferase 2 with N-acetyl-lactosamine | |
| 7JHN | Q9NY97 | Structure of human beta 1,3-N-acetylglucosaminyltransferase 2 with UDP and trisaccharide GlcNAc-beta1-3Gal-beta1-4GlcNAc | |
| 7JKS | 7JKS | Crystal structure of vaccine-elicited broadly neutralizing VRC01-class antibody 2411a in complex with HIV-1 gp120 core | |
| 7KE8 | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) | |
| 7KK8 | Q6J5N4 | Fluoride channel Fluc-Ec2 mutant S81T with bromide | |
| 7KK8 | 7KK8 | Fluoride channel Fluc-Ec2 mutant S81T with bromide | |
| 7KKB | Q6J5N4 | Fluoride channel Fluc-Ec2 mutant S81C with bromide | |
| 7KKB | 7KKB | Fluoride channel Fluc-Ec2 mutant S81C with bromide | |
| 7L63 | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose | |
| 7L64 | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Lewis-a | |
| 7L65 | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Methyl-GlcNAc | |
| 7L88 | 7L88 | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.32034 (Wk26 time point) | |
| 7L89 | 7L89 | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.32034 (Wk26 time point) | |
| 7LAE | P05164 | CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-4 | |
| 7LFK | Q31093 | MODEL OF MHC CLASS Ib H2-M3 WITH MOUSE ND1 N-TERMINAL HEPTAPEPTIDE, THR MUTANT, REFINED AT 1.60 ANGSTROMS RESOLUTION | |
| 7LFK | P01887 | MODEL OF MHC CLASS Ib H2-M3 WITH MOUSE ND1 N-TERMINAL HEPTAPEPTIDE, THR MUTANT, REFINED AT 1.60 ANGSTROMS RESOLUTION | |
| 7LFK | P03888 | MODEL OF MHC CLASS Ib H2-M3 WITH MOUSE ND1 N-TERMINAL HEPTAPEPTIDE, THR MUTANT, REFINED AT 1.60 ANGSTROMS RESOLUTION | |
| 7LL2 | Q2N0S6 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
| 7LL2 | Q2N0S7 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
| 7LL2 | 7LL2 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
| 7LLK | O55774 | Cryo-EM structure of Q23.17_DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody 179NC75 Fab | |
| 7LLK | 7LLK | Cryo-EM structure of Q23.17_DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody 179NC75 Fab | |
| 7LM8 | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients | |
| 7LM8 | 7LM8 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients | |
| 7LST | A0A2N0UU23 | Ruminococcus bromii Amy12-D392A with 63-a-D-glucosyl-maltotriosyl-maltotriose | |
| 7LSU | A0A2N0UU23 | Ruminococcus bromii Amy12-D392A with 63-a-D-glucosyl-maltotriose | |
| 7LYP | P0DTC2 | South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation | |
| 7MBU | S5UH55 | Cryo-EM structure of zebrafish TRPM5 E337A mutant in the presence of 5 mM calcium (high calcium occupancy in the transmembrane domain) | |
| 7MG6 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-AGCT |
